Download PDF
CC BY-NC-ND 4.0 · Int J Angiol
DOI: 10.1055/s-0044-1779660
Original Article

Are Hospital Admissions (Costs) and Mortality Rate Impacted by Guideline-driven Treatment of Heart Failure?: A Comparison between Participants in the “CorBene” CMP and Standard-care Patients on the Basis of Propensity Score Matching

Josef Ehling
1   Department of Imaging Diagnostics, German Air Force Centre for Aerospace Medicine, Köln, Germany
,
Hans Jürgen Noblé
1   Department of Imaging Diagnostics, German Air Force Centre for Aerospace Medicine, Köln, Germany
,
Detlef Gysan
2   Medizinisches Versorgungszentrum GbR, Köln, Germany
,
Mareike Möller
2   Medizinisches Versorgungszentrum GbR, Köln, Germany
,
Franz Goss
1   Department of Imaging Diagnostics, German Air Force Centre for Aerospace Medicine, Köln, Germany
,
Winfried Haerer
1   Department of Imaging Diagnostics, German Air Force Centre for Aerospace Medicine, Köln, Germany
,
Simon Glück
1   Department of Imaging Diagnostics, German Air Force Centre for Aerospace Medicine, Köln, Germany
,
Paul Martin Bansmann 
3   Köln, Germany
› Author Affiliations Funding Novartis gave financial support to the Institute for Cardiological and Pneumological Prevention within the framework of this research project.
› Further Information
   Permissions and Reprints

Abstract

Heart failure (HF) is one of the most common diagnoses on admission to hospital in Germany, and one which incurs high costs. Integrated care in case management programs (CMPs) aims to improve treatment quality in the sense of guideline-driven treatment, while reducing hospital admissions, hospital costs, and mortality. A total of 1,844 patient data records from 11 German statutory health insurance companies enrolled in the CMP (intervention group [IG]) were compared with 1,844 standard-care patients (control group) using propensity score matching. The two groups were assessed over three follow-up observation periods regarding the endpoints' treatment costs, hospitalization rate, indicators for treatment quality (diagnostics, physician contact), and mortality. The evaluation revealed no significant differences regarding overall costs. The IG incurred significantly higher outpatient costs, but the medication costs and inpatient costs were not significantly different. There were also no significant differences in the number of hospital admissions. Patients within the CMP had significantly more frequent contact with a cardiologist, and underwent echocardiographic examination significantly more frequently. Mortality during the first follow-up observation year was considerably more favorable for the IG. There are indications that treatment quality is improved in HF patients.

Keywords

angioplasty - artery - atherosclerosis - cardiac catheterization - cardiovascular disease - cardiovascular risk factors - coronary intervention

Ethical Approval

Ethical approval for this study was waived by the Ethics committee of the University Witten/Herdecke.


Availability of Data and Material

Statistical evaluations were performed by the Institute for Applied Health Research Berlin GmbH—InGef. An allowance was paid for data fusion and statistical evaluations. InGef is a subsidiary of spectrumK GmbH, which belongs to the Association of Professional and Guild Health Insurance Companies. Together with BNK Service GmbH—a subsidiary of the Professional Association of Cardiologists in Private Practice—spectrumK is one of the CorBene frame contract partners and responsible for participant management and billing control for the health insurance companies. Some of the health insurance companies participating in the evaluation are partners in the spectrumK GmbH company. The data underlying this article will be shared on reasonable request to the corresponding author.


Authors' Contributions

J.E., H.J.N., and P.M.B. contributed to the design and implementation of the research, to the analysis of the results and to the writing of the manuscript. He discussed the results and contributed to the final manuscript. D.G. provided critical feedback and helped shape the research, analysis, and manuscript. M.M., F.G., W.H., and S.G. contributed to the design and implementation of the research, to the analysis of the results and to the writing of the manuscript.




Publication History

Article published online:
09 February 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Roger VL. Epidemiology of heart failure. Circ Res 2013; 113 (06) 646-659
    Google Scholar
  • 2 Störk S, Handrock R, Jacob J. et al. Epidemiology of heart failure in Germany: a retrospective database study. Clin Res Cardiol 2017; 106 (11) 913-922
    Google Scholar
  • 3 Holstiege J, Akmatov MK, Störk S, Steffen A, Bätzing J. Higher prevalence of heart failure in rural regions: a population-based study covering 87% of German inhabitants. Clin Res Cardiol 2019; 108 (10) 1102-1106
    Google Scholar
  • 4 Cowie MR, Anker SD, Cleland JGF. et al. Improving care for patients with acute heart failure: before, during and after hospitalization. ESC Heart Fail 2014; 1 (02) 110-145
    Google Scholar
  • 5 Christ M, Störk S, Dörr M. et al; Trend HF Germany Project. Heart failure epidemiology 2000-2013: insights from the German Federal Health Monitoring System. Eur J Heart Fail 2016; 18 (08) 1009-1018
    Google Scholar
  • 6 Klauber J, Wasem J, Beivers A, Mostert C. Krankenhaus-Report 2021: Versorgungsketten–Der Patient im Mittelpunkt. Berlin, Germany: Springer Nature; 2021: 523
    Google Scholar
  • 7 Lund LH, Benson L, Dahlström U, Edner M. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction. JAMA 2012; 308 (20) 2108-2117
    Google Scholar
  • 8 Crespo-Leiro MG, Anker SD, Maggioni AP. et al; Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail 2016; 18 (06) 613-625
    Google Scholar
  • 9 Tromp J, Bamadhaj S, Cleland JGF. et al. Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. Lancet Glob Health 2020; 8 (03) e411-e422
    Google Scholar
  • 10 Deutscher Herzbericht. Sektorenübergreifende Versorgungsanalyse zur Kardiologie, Herzchirurgie und Kinderherzmedizin in Deutschland. Frankfurt, Germany: Deutsche Herzstiftung e.V. Thieme Verlag; 2020
    Google Scholar
  • 11 Statistisches Bundesamt. . Krankheitskostenrechnung Deutschland. 2022 Accessed October 01, 2022 at: https://www-genesis.destatis.de/genesis/online?sequenz=tabelleErgebnis&selectionname=23631–0001&sachmerkmal=ICD10Y&sachschluessel=ICD10–I00–I99,ICD10–I10–I15,ICD10–I20–I25,ICD10–I21,ICD10–I22,Icd10–I30–I52,ICD10–I50,ICD10–I60–I69,ICD10–I60–I61,ICD10–I63,ICD10–I64,ICD10–I69,ICD10–I80–I89,ICD10–I83#abreadcrumb
  • 12 Maggioni AP, Anker SD, Dahlström U. et al; Heart Failure Association of the ESC. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 2013; 15 (10) 1173-1184
    Google Scholar
  • 13 Riens B, Bätzing Jörg. Leitliniengerechte Therapie bei Herzinsuffizienz. 2014: 1-28 DOI: 10.20364/VA-14.03
    Google Scholar
  • 14 Ouwerkerk W, Voors AA, Anker SD. et al. Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study. Eur Heart J 2017; 38 (24) 1883-1890
    Google Scholar
  • 15 Gandhi S, Mosleh W, Sharma UC, Demers C, Farkouh ME, Schwalm JD. Multidisciplinary heart failure clinics are associated with lower heart failure hospitalization and mortality: systematic review and meta-analysis. Can J Cardiol 2017; 33 (10) 1237-1244
    Google Scholar
  • 16 Ponikowski P, Voors AA, Anker SD. et al; ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37 (27) 2129-2200
    Google Scholar
  • 17 Society of Cardiology (ESC). Deutsche Gesellschaft für Kardiologie (DGK). Deutsche Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. Pocket-Leitlinie: Herzinsuffizienz (Version 2016). 2016. Börm Bruckmeier Verlag GmbH, Grünwald, 2. Auflage, 2017. Accessed: 01 October, 2022 at: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Guidelines-derivative-products/Pocket-Guidelines
  • 18 Hendricks V, Schmidt S, Vogt A. et al. Case-Management-Programm für Patienten mit chronischer Herzinsuffizienz: Effektivität in Bezug auf die Mortalität, Krankenhauseinweisungen und-kosten. Dtsch Arztebl 2014; 111 (15) 264-270
    Google Scholar
  • 19 Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70 (01) 41-55
    Google Scholar
  • 20 Bocchi EA, da Cruz FDD, BrandÃo SM. et al. Cost-effectiveness benefits of a disease management program: the REMADHE Trial Results. J Card Fail 2018; 24 (10) 627-637
    Google Scholar
  • 21 Maru S, Byrnes J, Carrington MJ, Stewart S, Scuffham PA. Systematic review of trial-based analyses reporting the economic impact of heart failure management programs compared with usual care. Eur J Cardiovasc Nurs 2016; 15 (01) 82-90
    Google Scholar
  • 22 Takeda A, Martin N, Taylor RS, Taylor SJ. Disease management interventions for heart failure. Cochrane Database Syst Rev 2019; 1 (01) CD002752
    Google Scholar
  • 23 Ross JS, Chen J, Lin Z. et al. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail 2010; 3 (01) 97-103
    Google Scholar
  • 24 Klauber J. Krankenhaus-Report 2016: Schwerpunkt: Ambulant im Krankenhaus. Schattauer Verlag; 2016
    Google Scholar
  • 25 Roehl I, Beyer M, Gondan M. et al. Leitliniengerechte Behandlung bei chronischer Herzinsuffizienz im Rahmen der Hausarztzentrierten Versorgung. Ergebnisse einer Evaluationsstudie. Z Evid Fortbild Qual Gesundhwes 2013; 107 (06) 394-402
    Google Scholar
  • 26 Gysan D, Pfister R, Bansmann M. et al. Herzinsuffizienzbehandlung in Integrierten Versorgungsmodellen nach § 140 SGB V. Aktuelle Kardiologie 2021; 10 (03) 240-244
    Google Scholar